Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Shares Outstanding Shares Outstanding Shares Repurchased Short-Term Debt issuances

Cumberland Pharmaceuticals (CPIX) Shares Issued (2018)

Cumberland Pharmaceuticals' Shares Issued history spans 6 years, with the latest figure at -$909.0 for Q4 2018.

On a quarterly basis, Shares Issued changed N/A to -$909.0 in Q4 2018 year-over-year; TTM through Sep 2019 was -$909.0, a 100.45% decrease, with the full-year FY2018 number at $200000.0, changed N/A from a year prior.
Shares Issued hit -$909.0 in Q4 2018 for Cumberland Pharmaceuticals, down from $909.0 in the prior quarter.
Over the last five years, Shares Issued for CPIX hit a ceiling of $200000.0 in Q1 2018 and a floor of -$909.0 in Q4 2018.